+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

HIV or AIDS Diagnostics Market Research Report by Product Type (Instruments and Kits & Reagents), Test Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4904396
  • Report
  • April 2022
  • Region: Global
  • 188 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Siemens Healthineers AG
The Global HIV or AIDS Diagnostics Market size was estimated at USD 3,660.47 million in 2021, USD 3,978.66 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.86% to reach USD 6,095.06 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the HIV or AIDS Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Instruments and Kits & Reagents.
  • Based on Test Type, the market was studied across ELISA, Nucleic Acid Tests, and Rapid Tests.
  • Based on End User, the market was studied across Academic & Research Institutes, Hospitals, and Private Diagnostics Laboratories.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for HIV or AIDS Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the HIV or AIDS Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global HIV or AIDS Diagnostics Market, including Abbott Laboratories, Alere Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., OraSure Technologies, Inc., and Siemens Healthineers AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global HIV or AIDS Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global HIV or AIDS Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global HIV or AIDS Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global HIV or AIDS Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global HIV or AIDS Diagnostics Market?
6. What is the market share of the leading vendors in the Global HIV or AIDS Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global HIV or AIDS Diagnostics Market?
Frequently Asked Questions about the Global HIV or AIDS Diagnostics Market

What is the estimated value of the Global HIV or AIDS Diagnostics Market?

The Global HIV or AIDS Diagnostics Market was estimated to be valued at $3660.5 Million in 2021.

What is the growth rate of the Global HIV or AIDS Diagnostics Market?

The growth rate of the Global HIV or AIDS Diagnostics Market is 8.8%, with an estimated value of $6095.1 Million by 2027.

What is the forecasted size of the Global HIV or AIDS Diagnostics Market?

The Global HIV or AIDS Diagnostics Market is estimated to be worth $6095.1 Million by 2027.

Who are the key companies in the Global HIV or AIDS Diagnostics Market?

Key companies in the Global HIV or AIDS Diagnostics Market include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, Bio, Rad Laboratories, Inc., Chembio Diagnostic Systems Inc., Danaher Corporation, F. Hoffmann and Hologic, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Siemens Healthineers AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of blood transfusions and blood donations
5.1.1.2. Increasing government initiatives for awareness
5.1.1.3. Growth in prevalence of HIV due to unprotected sex
5.1.2. Restraints
5.1.2.1. High cost of Nucleic acid tests (NAT)
5.1.3. Opportunities
5.1.3.1. Advanced diagnostic methods exploring new ways of treatment
5.1.3.2. Innovative technologies for early infant diagnosis of HIV
5.1.4. Challenges
5.1.4.1. Increase in use of home access kits and instruments
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. HIV or AIDS Diagnostics Market, by Product Type
6.1. Introduction
6.2. Instruments
6.3. Kits & Reagents
7. HIV or AIDS Diagnostics Market, by Test Type
7.1. Introduction
7.2. ELISA
7.3. Nucleic Acid Tests
7.4. Rapid Tests
8. HIV or AIDS Diagnostics Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals
8.4. Private Diagnostics Laboratories
9. Americas HIV or AIDS Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific HIV or AIDS Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa HIV or AIDS Diagnostics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Alere Inc.
13.3. Becton Dickinson and Company
13.4. Bio-Rad Laboratories, Inc.
13.5. Chembio Diagnostic Systems Inc.
13.6. Danaher Corporation
13.7. F. Hoffmann-La Roche Ltd.
13.8. Hologic, Inc.
13.9. OraSure Technologies, Inc.
13.10. Siemens Healthineers AG
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: DYNAMICS
FIGURE 2. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2027
FIGURE 12. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 19. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2027
FIGURE 21. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. AUSTRALIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. INDIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. INDONESIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. JAPAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. MALAYSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. PHILIPPINES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. SINGAPORE HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. SOUTH KOREA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. TAIWAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. THAILAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HIV OR AIDS DIAGNOSTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY PRIVATE DIAGNOSTICS LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. AUSTRALIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. INDIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. INDONESIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. JAPAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. MALAYSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. PHILIPPINES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. SINGAPORE HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. SOUTH KOREA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. TAIWAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. THAILAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: SCORES
TABLE 77. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: RANKING
TABLE 80. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 81. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 82. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 83. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 84. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 85. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 86. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Alere Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Siemens Healthineers AG
Note: Product cover images may vary from those shown

Loading
LOADING...